The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 1, 2007, Pages 138-143

  Chen, Allen M ^a   Garcia, Joaquin ^b   Bucci, M Kara ^a   Quivey, Jeanne M ^a   Eisele, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carcinoma; Parotid gland; Pleomorphic adenoma; Radiation therapy

Indexed keywords

BIOLOGICAL ORGANS; ONCOLOGY; PATIENT TREATMENT; TUMORS;

CARCINOMA; PAROTID GLAND; PLEOMORPHIC ADENOMA;

RADIOTHERAPY;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND CANCER; PLEOMORPHIC ADENOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SALIVARY GLAND DUCT; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADENOMA, PLEOMORPHIC; ADULT; AGED; CARCINOMA, ADENOID CYSTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAROTID NEOPLASMS; POSTOPERATIVE PERIOD; RADIOTHERAPY DOSAGE; SALIVARY DUCTS; SALIVARY GLAND NEOPLASMS;

EID: 33845625645     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.07.1380     Document Type: Article

References (23)

1. Beahrs O.H., Wololner L.B., Kirklin J.W., et al. Carcinomatous transformation of mixed tumors of the parotid gland. AMA Arch Surg 75 (1957) 605-614
2. Gnepp D.R. Malignant mixed tumours of salivary gland, a review. Pathol Ann 28 (1993) 279-328
3. Eneroth C.M., and Zetterberg A. Malignancy in pleomorphic adenoma. A clinical and microspectrophotometric study. Acta Otolaryngol 77 (1974) 426-432
4. El-Naggar A.K., Hurr K., Kagan J., et al. Genotype alterations in benign and malignant salivary gland tumors: Histogenetic and clinical implications. Am J Surg Pathol 21 (1997) 691-697
5. Li X., Tsuji T., Wen S., et al. Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma: Correlation with p53 expression. Cancer (1997) 2314-2319
6. Yamamoto Y., Kishimoto Y., Wistuba I.I., et al. DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: Comparison of molecular study and p53 immunostaining. Pathol Int 48 (1998) 265-272
7. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 547-581
8. Cox D.R., and Oakes N. Analysis of survival data (1988), Chapman and Hall, New York
9. Saiga H., Kaneko T., and Matsuzaki O. Histopathologic studies on carcinoma in carcinoma in pleomorphic adenoma of parotid gland. Cancer 48 (1981) 113-121
10. Kane W.J., McCaffrey T.V., Olsen K.D., et al. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117 (1991) 307-315
11. Harbo G., Bundgaard T., Pedersen D., et al. Prognostic indicators for malignant tumours of the parotid gland. Clin Otolaryngol 27 (2002) 512-516
12. Patey D.H., Thackray A.C., and Keeling D.H. Malignant disease of the parotid. Br J Cancer 19 (1965) 712-737
13. Lewis J.E., Olsen K.D., and Sebo T.J. Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases. Hum Pathol 32 (2001) 596-604
14. Gerughty R.M., Scofield H.H., Brown F.M., et al. Malignant mixed tumors of salivary gland origin. Cancer 24 (1969) 471-486
15. LiVolsi V.A., and Perzin K.H. Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: A clinicopathologic study. Cancer 39 (1977) 2209-2230
16. Olsen K.D., and Lewis J.E. Carcinoma ex pleomorphic adenoma: A clinicopathologic review. Head Neck 23 (2001) 705-712
17. Garden A.S., El-Naggar A.K., Morrison W.H., et al. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 37 (1997) 79-85
18. Spiro R.H., Huvos A.G., and Strong E.W. Malignant mixed tumor of salivary origin: A clinicopathologic study of 146 cases. Cancer 39 (1977) 388-396
19. Bhattacharyya N., and Fried M.P. Determinants of survival in parotid gland carcinoma: A population-based study. Am J Otolaryngol 26 (2005) 39-44
20. Honk W.K., Bromer R.H., Amato D.A., et al. Patterns of relapse in locally advanced head and neck cancer patients who achieved complete remission after combined modality treatment. Cancer 45 (1985) 1242-1245
21. Nouraei S.A., Hope K.L., Kelly C.G., et al. Carcinoma ex benign pleomorphic adenoma of the parotid gland. Plast Reconstr Surg 116 (2005) 1206-1213
22. Tortoledo M.E., Luna M.A., and Batsakis J.G. Carcinomas ex pleomorphic adenoma and malignant mixed tumors. Histomorphologic indexes. Arch Otolaryngol 110 (1984) 172-176
23. Brandwein M., Huvos A.G., Dardick I., et al. Noninvasive and minimally invasive carcinoma ex mixed tumor: A clinicopathologic and ploidy study of 12 patients with major salivary gland tumors of low (or no?) malignant potential. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81 (1996) 655-664